 |
PDBsum entry 6y6h
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
63:14626-14646
(2020)
|
|
PubMed id:
|
|
|
|
|
| |
|
A Chemical Probe for Dark Kinase STK17B Derives Its Potency and High Selectivity through a Unique P-Loop Conformation.
|
|
A.Picado,
A.Chaikuad,
C.I.Wells,
S.Shrestha,
W.J.Zuercher,
J.E.Pickett,
F.E.Kwarcinski,
P.Sinha,
C.S.de Silva,
R.Zutshi,
S.Liu,
N.Kannan,
S.Knapp,
D.H.Drewry,
T.M.Willson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
STK17B is a member of the death-associated protein kinase family and has been
genetically linked to the development of diverse diseases. However, the role of
STK17B in normal and disease pathology is poorly defined. Here, we present the
discovery of thieno[3,2-d] pyrimidine SGC-STK17B-1 (11s), a
high-quality chemical probe for this understudied "dark" kinase.
11s is an ATP-competitive inhibitor that showed remarkable selectivity
over other kinases including the closely related STK17A. X-ray crystallography
of 11s and related thieno[3,2-d]pyrimidines bound to STK17B revealed a
unique P-loop conformation characterized by a salt bridge between R41 and the
carboxylic acid of the inhibitor. Molecular dynamic simulations of STK17B
revealed the flexibility of the P-loop and a wide range of R41 conformations
available to the apo-protein. The isomeric thieno[2,3-d]pyrimidine
SGC-STK17B-1N (19g) was identified as a negative control compound.
The >100-fold lower activity of 19g on STK17B was attributed to the
reduced basicity of its pyrimidine N1.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |